Cargando…
PPARγ Variant Influences Angiographic Outcome and 10-Year Cardiovascular Risk in Male Symptomatic Coronary Artery Disease Patients
OBJECTIVE: Activation of peroxisome proliferator–activated receptor (PPAR)-γ signaling influences metabolic profiles and the propensity toward inflammation. Small-molecule stimulation of PPARγ is investigated for secondary prevention of cardiovascular disease. The common PPARγ Pro12Ala variant has f...
Autores principales: | Regieli, Jakub J., Jukema, J. Wouter, Doevendans, Pieter A., Zwinderman, Aeilko H., van der Graaf, Yolanda, Kastelein, John J., Grobbee, Diederick E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671091/ https://www.ncbi.nlm.nih.gov/pubmed/19228871 http://dx.doi.org/10.2337/dc08-1819 |
Ejemplares similares
-
Metabolic Background Determines the Importance of NOS3 Polymorphisms in Restenosis after Percutaneous Coronary Intervention: A Study in Patients with and without the Metabolic Syndrome
por: Pons, Douwe, et al.
Publicado: (2009) -
Estimating effects of rare haplotypes on failure time using a penalized Cox proportional hazards regression model
por: Souverein, Olga W, et al.
Publicado: (2008) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012) -
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
por: Grobbee, Esmée J., et al.
Publicado: (2022) -
Erratum: PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors
por: Kotlinowski, Jerzy, et al.
Publicado: (2015)